Professional Documents
Culture Documents
SDS_TUBALL_BATT_NMP_PVDF_EU_ENG_V1-1_(ES extended)
SDS_TUBALL_BATT_NMP_PVDF_EU_ENG_V1-1_(ES extended)
SDS_TUBALL_BATT_NMP_PVDF_EU_ENG_V1-1_(ES extended)
1.2. Relevant identified uses of the substance or mixture and uses advised against
1.2.1. Relevant identified uses
Use of the substance/mixture : Industrial use as additive in metal and/or ceramic composites
Supplier
Europe:
OCSiAl Europe S.a.r.l.
L-3364, Leudelange,
1, rue de la Poudrerie,
Grand Duchy of
Luxembourg
T +352 27 99 03 73
09.00-17.00 GMT+2
europe@ocsial.com
GHS07 GHS08
Component
Single wall carbon nanotubes This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII
This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII
N-methyl-2-pyrrolidone This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII
This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII
The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting
properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation
(EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
Component
N-methyl-2-pyrrolidone The substance is not included in the list established in accordance with Article 59(1) of
REACH for having endocrine disrupting properties, or is not identified as having endocrine
disrupting properties in accordance with the criteria set out in Commission Delegated
Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
3.1. Substances
Not applicable
3.2. Mixtures ►
Single wall carbon nanotubes** (CAS-No.) Not assigned for EU-REACH 0.1 – 1 Eye Irrit. 2, H319
(EC-No.) 943-098-9
(REACH-No.) 01-2120130006-75-0000
Components – Nanoform
Name of (set of) nanoform(s) Tuball™ - all grades are part of one set of nanoform
Crystallinity Amorphous
4.2. Most important symptoms and effects, both acute and delayed
Symptoms/effects after inhalation : May cause irritation to the respiratory tract.
Symptoms/effects after skin contact : Causes skin irritation.
Symptoms/effects after eye contact : Causes serious eye irritation.
Chronic symptoms : May damage the unborn child.
4.3. Indication of any immediate medical attention and special treatment needed
Treat symptomatically.
Heat and ignition sources : Keep away from open flames, hot surfaces and sources of ignition. No smoking.
Information on mixed storage : Store away from water (including sewage plant).
Storage area : Store in a well-ventilated place.
Special rules on packaging : Keep container tightly closed.
N-methyl-2-pyrrolidone
EU - Indicative Occupational Exposure Limit (IOEL)
Remark Skin
Remark D: la mention “D” signifie que la résorption de l’agent, via la peau, les muqueuses ou les
yeux, constitue une partie importante de l’exposition totale. Cette résorption peut se faire
tant par contact direct que par présence de l’agent dans l’air. # D: de vermelding “D”
betekent dat de opname van het agens via de huid, de slijmvliezen of de ogen een
belangrijk deel van de totale blootstelling vormt. Deze opname kan het gevolg zijn van
zowel direct contact als zijn aanwezigheid in de lucht.
Remark Кожа (възможна е значителна резорбция чрез кожата); • (Химични агенти, за които
са определени гранични стойности във въздуха на работната среда за Европейската
общност)
N-methyl-2-pyrrolidone
Regulatory reference Наредба № 13 от 30.12.2003 г. за защита на работещите от рискове, свързани с
експозиция на химични агенти при работа (изм. и доп. ДВ. бр. 47 от 2021 г., в сила от
04.06.2021 г.)
Remark Direktiva: 2009/161/EU. Napomena: Koža (razvrstana kao tvar koja nadražuje kožu
(H315)), Repr 1B
Regulatory reference Pravilnik o zaštiti radnika od izloženosti opasnim kemikalijama na radu, graničnim
vrijednostima izloženosti i biološkim graničnim vrijednostima (NN 1/2021)
Regulatory reference Pravilnik o zaštiti radnika od izloženosti opasnim kemikalijama na radu, graničnim
vrijednostima izloženosti i biološkim graničnim vrijednostima (NN 91/2018)
Remark δέρμα
Remark D - při expozici se významně uplatňuje pronikání faktoru kůží, I - dráždí sliznice (oči,
dýchací cesty), respektive kůži, T - toxický pro reprodukci kategorie 1A a 1B (s větou
H360 včetně příslušných kódů).
Remark E (betyder, at stoffet har en EF-grænseværdi); H (betyder, at stoffet kan optages gennem
huden)
N-methyl-2-pyrrolidone
Regulatory reference BEK nr 202 af 21/02/2023
Remark Iho
Regulatory reference Arrêté du 30 juin 2004 modifié (réf.: INRS ED 984, 2016)
Remark EU - Europäische Union (Von der EU wurde ein Luftgrenzwert festgelegt: Abweichungen
bei Wert und Spitzenbegrenzung sind möglich); DFG - Senatskommission zur Prüfung
gesundheitsschädlicher Arbeitsstoffe der DFG (MAK-Kommission); AGS - Ausschuss für
Gefahrstoffe; H - hautresorptiv; Y - Ein Risiko der Fruchtschädigung braucht bei
Einhaltung des Arbeitsplatzgrenzwertes und des biologischen Grenzwertes (BGW) nicht
befürchtet zu werden; 11 - Summe aus Dampf und Aerosolen; 19 - Die Senatskommission
zur Prüfung gesundheitsschädlicher Arbeitsstoffe der DFG hat in der MAK- und BAT-
Werte-Liste zum gleichlautenden MAK-Wert auch einen BAT-Wert festgelegt; 32 - Gemäß
Änderung von Anhang XVII der Verordnung (EG) Nr. 1907/2006 (https://eur-
lex.europa.eu/legal-content/DE/TXT/PDF/?uri=CELEX:32018R0588&from=DE) gilt ab 10.
Mai 2020 eine Verwendungsbeschränkung für NMP, wenn der dort genannte
Luftgrenzwert nicht eingehalten wird
Biological limit value 150 mg/l Parameter: 5-Hydroxy- N-methyl-2-pyrrolidon - Untersuchungsmaterial: U = Urin
- Probenahmezeitpunkt: b) Expositionsende, bzw. Schichtende - Festlegung/Begründung:
05/2013 DFG
N-methyl-2-pyrrolidone
Remark Η ένδειξη «δέρμα» στις οριακές τιμές επαγγελματικής έκθεσης επισημαίνει το ενδεχόμενο
σημαντικής διείσδυσης μέσω του δέρματος.
Regulatory reference Π.Δ. 12/2012 - Προστασία της υγείας των εργαζομένων που εκτίθενται σε ορισμένους
χημικούς παράγοντες κατά τη διάρκεια της εργασίας τους
Remark b (Bőrön át is felszívódik); EU3 (2009/161 /EK irányelvben közölt érték); T (Azok az
anyagok, amelyek egészségkárosító hatása TARTÓS expozíciót követően jelentkezik)
Regulatory reference 5/2020. (II. 6.) ITM rendelet - A kémiai kóroki tényezők hatásának kitett munkavállalók
egészségének és biztonságának védelméről
Remark Cute
Remark H (Huidopname) Stoffen die relatief gemakkelijk door de huid kunnen worden opgenomen,
hetgeen een substantiële bijdrage kan betekenen aan de totale inwendige blootstelling,
hebben in de lijst een H-aanduiding. Bij deze stoffen moeten naast maatregelen tegen
inademing ook adequate maatregelen ter voorkoming van huidcontact worden genomen.
Remark P - posibilitatea unei penetrări cutanate importante; R1B - poate dăuna fătului; poate
dăuna fertilității
N-methyl-2-pyrrolidone
OEL STEL 80 mg/m³
Regulatory reference ПРАВИЛНИК о превентивним мерама за безбедан и здрав рад при излагању
хемијским материјама (,,Службени гласник РС”, бр. 106/09, 117/17 и 107/21)
Remark K (Lastnost lažjega prehajanja snovi v organizem skozi kožo), Y (Snovi, pri katerih ni
nevarnosti za zarodek ob upoštevanju mejnih vrednosti in bat vrednosti), BAT (Biološka
mejna vrednost), EU
BLV 150 mg/l Parameter: 5‐hidroksi‐N‐metil‐2‐pirolidin - Biološki vzorec: urin - Čas vzorčenja:
ob koncu delovne izmene
N-methyl-2-pyrrolidone
Remark Vía dérmica (Indica que, en las exposiciones a esta sustancia, la aportación por la vía
cutánea puede resultar significativa para el contenido corporal total si no se adoptan
medidas para prevenir la absorción. En estas situaciones, es aconsejable la utilización del
control biológico para poder cuantificar la cantidad global absorbida del contaminante),
VLI (Agente químico para el que la U.E. estableció en su día un valor límite indicativo),
VLB® (Agente químico que tiene Valor Límite Biológico), TR1B (Cuando las pruebas
utilizadas para la clasificación procedan principalmente de datos en animales), r (Esta
sustancia tiene establecidas restricciones a la fabricación, la comercialización o el uso en
los términos especificados en el “Reglamento (CE) nº 1907/2006 sobre Registro,
Evaluación, Autorización y Restricción de sustancias y preparados químicos” (REACH) de
18 de diciembre de 2006 (DOUE L 369 de 30 de diciembre de 2006). Las restricciones de
una sustancia pueden aplicarse a todos los usos o sólo a usos concretos. El anexo XVII
del Reglamento REACH contiene la lista de todas las sustancias restringidas y especifica
los usos que se han restringido).
Regulatory reference Límites de Exposición Profesional para Agentes Químicos en España 2023. INSHT
Regulatory reference Límites de Exposición Profesional para Agentes Químicos en España 2023. INSHT
Remark H (Ämnet kan lätt upptas genom huden. Det föreskrivna gränsvärdet bedöms ge tillräckligt
skydd endast under förutsättning att huden är skyddad mot exponering för ämnet ifråga);
R (Ämnet är reproduktionsstörande. Med reproduktionsstörande ämnen avses ämnen
som kan medföra skadliga effekter på fortplantningsförmågan eller avkommans
utveckling)
Remark H: Kjemikalier som kan tas opp gjennom huden; R: Kjemikalier som skal betraktes som
reproduksjonstoksiske; E: EU har en veiledende grenseverdi og/eller anmerkning for
stoffet.
KTV 4
N-methyl-2-pyrrolidone
Short time value [ppm] 76 ppm
Remark INRS
PNEC (Water)
PNEC (Sediment)
PNEC (Soil)
PNEC (Oral)
PNEC oral (secondary poisoning) No potential to cause toxic effects if accumulated (in higher organisms) via the food chain
PNEC (STP)
PNEC sewage treatment plant No data available: testing technically not feasible
N-methyl-2-pyrrolidone
DNEL/DMEL (Workers)
PNEC (Water)
PNEC (Sediment)
PNEC (Soil)
PNEC (STP)
Hand protection:
Chemically resistant protective gloves
Hand protection
Respiratory protection:
Wear respiratory protection
Respiratory protection
Gas filters Type A - High-boiling (>65 °C) If conc. in air > exposure limit EN 14387
organic compounds
Gas filters Type A-P2, (APF >= 10) Mist formation, Protection for EN 14387
Liquid particles
10.1. Reactivity
Stable under normal conditions.
N-methyl-2-pyrrolidone
LD50 oral rat < 4150 mg/kg - OECD 401
NOAEL (animal, F1) > 1000 mg/kg bw/day - for adverse effects on prenatal development (conceptus to birth) -
OECD 422
NOAEL (animal, F1) > 1000 mg/kg bw/day - for adverse effects on postnatal development (pup) - OECD 422
N-methyl-2-pyrrolidone
NOAEL (animal/male, F0/P) 160 mg/kg bodyweight
N-methyl-2-pyrrolidone
STOT-single exposure May cause respiratory irritation.
STOT-repeated exposure : Not available
12.1. Toxicity
Hazardous to the aquatic environment, short–term : Not classified.
(acute)
Hazardous to the aquatic environment, long–term : Not classified.
(chronic)
Not rapidly degradable
N-methyl-2-pyrrolidone
EC50 crustacea - 48h > 1000 mg/l Daphnia magna (Water flea)
NOEC chronic crustacea - 21 days 12.5 mg/l Daphnia magna (Water flea)
N-methyl-2-pyrrolidone
Persistence and degradability Readily biodegradable.
N-methyl-2-pyrrolidone
Partition coefficient n-octanol/water (Log Pow) ≥ -0.54
Component
Single wall carbon nanotubes This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII
This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII
N-methyl-2-pyrrolidone This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII
This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII
Waste treatment methods : Disposal through controlled incineration or authorised waste dump.
Sewage disposal recommendations : Prevent entry to sewers and public waters.
Product/Packaging disposal recommendations : Dispose of contents/container to hazardous or special waste collection point, in accordance
with local, regional, national and/or international regulation.
Additional information : Clean up even minor leaks or spills if possible without unnecessary risk.
European List of Waste (LoW) code : 06 13 99 - wastes not otherwise specified
Not regulated Not regulated Not regulated Not regulated Not regulated
Transport by sea
Not regulated
Air transport
Not regulated
Rail transport
Not regulated
15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture
15.1.1. EU-Regulations
3(b) Pyrrolidinone, dimethyl- Substances or mixtures fulfilling the criteria for any of the following hazard classes or
categories set out in Annex I to Regulation (EC) No 1272/2008: Hazard classes 3.1 to 3.6,
3.7 adverse effects on sexual function and fertility or on development, 3.8 effects other
than narcotic effects, 3.9 and 3.10
30. N-methyl-2-pyrrolidone Substances which are classified as reproductive toxicant category 1A or 1B in Part 3 of
Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 5 or Appendix 6,
respectively.
France
Occupational diseases
Code Description
RG 84 Conditions caused by liquid organic solvents for professional use: saturated or unsaturated aliphatic or cyclic liquid
hydrocarbons and mixtures thereof; liquid halogenated hydrocarbons; nitrated derivatives of aliphatic hydrocarbons;
alcohols; glycols, glycol ethers; ketones; aldehydes; aliphatic and cyclic ethers, including tetrahydrofuran; esters;
dimethylformamide and dimethylacetamine; acetonitrile and propionitrile; pyridine; dimethylsulfone and
dimethylsulfoxide
Germany
Employment restrictions : Observe restrictions according Act on the Protection of Working Mothers (MuSchG).
Observe restrictions according Act on the Protection of Young People in Employment
(JArbSchG).
Water hazard class (WGK) : WGK 1, Slightly hazardous to water (Classification according to AwSV, Annex 1).
Chemicals Prohibition Ordinance (ChemVerbotsV) : This product is subject to ChemVerbotsV Annex 2 Entry 1. The following requirements must
be observed: authorization requirement (according to § 6 paragraph 1 sentence 1), basic
requirements for carrying out the delivery (according to § 8 paragraph 1, 3 and 4),
identification and documentation (according to § 9 paragraph 1 to 3) and exclusion of the
shipping route (according to § 10).
Hazardous Incident Ordinance (12. BImSchV) : Is not subject of the Hazardous Incident Ordinance (12. BImSchV)
Netherlands
SZW-lijst van kankerverwekkende stoffen : None of the components are listed
SZW-lijst van mutagene stoffen : None of the components are listed
SZW-lijst van reprotoxische stoffen – Borstvoeding : None of the components are listed
SZW-lijst van reprotoxische stoffen – : None of the components are listed
Vruchtbaarheid
SZW-lijst van reprotoxische stoffen – Ontwikkeling : N-methyl-2-pyrrolidone new is listed
Denmark
Class for fire hazard : Class III-1
Store unit : 50 liter
Classification remarks : Flammable according to the Danish Ministry of Justice; Emergency management guidelines
for the storage of flammable liquids must be followed
Danish National Regulations : Young people below the age of 18 years are not allowed to use the product
Pregnant/breastfeeding women working with the product must not be in direct contact with
the product
For the following substances of this mixture a chemical safety assessment has been carried out:
Single wall carbon nanotubes
N-methyl-2-pyrrolidone
ADR European Agreement concerning the International Carriage of Dangerous Goods by Road
EN European Standard
REACH Registration, Evaluation, Authorisation and Restriction of Chemicals Regulation (EC) No 1907/2006
STOT SE 3 Specific target organ toxicity – Single exposure, Category 3, Respiratory tract irritation
This information is based on our current knowledge and is intended to describe the product for the purposes of health, safety and environmental
requirements only. It should not therefore be construed as guaranteeing any specific property of the product.
1. Industrial; Formulation
Formulation
ES Type: Worker Issue date: 01/09/2020
Version: 3.0 Revision date: 14/11/2022
Amount used, frequency and duration of use (or from service life)
Daily amount per site ≤ 0.333 t/d
1.2.2. Control of worker exposure: Contributing scenario controlling worker exposure (PROC3)
PROC3 Manufacture or formulation in the chemical industry in closed batch processes with
occasional controlled exposure or processes with equivalent containment condition
Concentration of substance in product Covers percentage substance in the product up to 100 % (unless stated differently)
Vapour pressure @ 25 °C
66 Pa
Conditions and measures related to personal protection, hygiene and health evaluation
Wear a respirator which reduces the air impurities by at least a factor of 10 (APF >= 10)
1.2.3. Control of worker exposure: Contributing scenario controlling worker exposure (PROC4)
Concentration of substance in product Covers percentage substance in the product up to 100 % (unless stated differently)
Vapour pressure @ 25 °C
66 Pa
Conditions and measures related to personal protection, hygiene and health evaluation
Wear a respirator which reduces the air impurities by at least a factor of 10 (APF >= 10)
1.2.4. Control of worker exposure: Contributing scenario controlling worker exposure (PROC5)
Concentration of substance in product Covers percentage substance in the product up to 100 % (unless stated differently)
Vapour pressure @ 25 °C
66 Pa
Conditions and measures related to personal protection, hygiene and health evaluation
Wear chemically resistant gloves (tested to EN374) in combination with 'basic' employee
training
Wear a respirator which reduces the air impurities by at least a factor of 10 (APF >= 10)
Man via environment - Inhalation (systemic effects) 0.00191 mg/m³ < 0.01 EUSES 2.1.2
Man via environment - Inhalation (local effects) 0.00191 mg/m³ < 0.01 EUSES 2.1.2
Man via environment - Oral 0.161 mg/kg bw/day 0.189 EUSES 2.1.2
1.4. Guidance to Downstream User to evaluate whether he works inside the boundaries set by the ES
1.4.1. Environment
1.4.2. Health
2. Industrial; Formulation
Formulation
ES Type: Worker Issue date: 01/09/2020
Version: 3.0 Revision date: 14/11/2022
Amount used, frequency and duration of use (or from service life)
Daily amount per site ≤ 0.333 t/d
2.2.2. Control of worker exposure: Contributing scenario controlling worker exposure (PROC8a)
Concentration of substance in product Covers percentage substance in the product up to 100 % (unless stated differently)
Vapour pressure @ 25 °C
66 Pa
Conditions and measures related to personal protection, hygiene and health evaluation
Wear a respirator which reduces the air impurities by at least a factor of 10 (APF >= 10)
2.2.3. Control of worker exposure: Contributing scenario controlling worker exposure (PROC8b)
Concentration of substance in product Covers percentage substance in the product up to 100 % (unless stated differently)
Vapour pressure @ 25 °C
66 Pa
Conditions and measures related to personal protection, hygiene and health evaluation
Wear a respirator which reduces the air impurities by at least a factor of 10 (APF >= 10)
2.2.4. Control of worker exposure: Contributing scenario controlling worker exposure (PROC9)
PROC9 Transfer of substance or preparation into small containers (dedicated filling line, including
weighing)
Concentration of substance in product Covers percentage substance in the product up to 100 % (unless stated differently)
66 Pa
Conditions and measures related to personal protection, hygiene and health evaluation
Wear a respirator which reduces the air impurities by at least a factor of 10 (APF >= 10)
2.2.5. Control of worker exposure: Contributing scenario controlling worker exposure (PROC15)
Concentration of substance in product Covers percentage substance in the product up to 100 % (unless stated differently)
Vapour pressure @ 25 °C
66 Pa
Conditions and measures related to personal protection, hygiene and health evaluation
Wear a respirator which reduces the air impurities by at least a factor of 10 (APF >= 10)
Man via environment - Inhalation (systemic effects) 0.00191 mg/m³ < 0.01 EUSES 2.1.2
Man via environment - Inhalation (local effects) 0.00191 mg/m³ < 0.01 EUSES 2.1.2
Man via environment - Oral 0.161 mg/kg bw/day 0.189 EUSES 2.1.2
2.4. Guidance to Downstream User to evaluate whether he works inside the boundaries set by the ES
2.4.1. Environment
2.4.2. Health
ERC4 Use of non-reactive processing aid at industrial site (no inclusion into or onto article)
Amount used, frequency and duration of use (or from service life)
Daily amount per site ≤ 0.333 t/d
3.2.2. Control of worker exposure: Contributing scenario controlling worker exposure (PROC1)
Concentration of substance in product Covers percentage substance in the product up to 100 % (unless stated differently)
Vapour pressure @ 25 °C
66 hPa
Conditions and measures related to personal protection, hygiene and health evaluation
Wear a respirator which reduces the air impurities by at least a factor of 10 (APF >= 10)
3.2.3. Control of worker exposure: Contributing scenario controlling worker exposure (PROC2)
PROC2 Chemical production or refinery in closed continuous process with occasional controlled
exposure or processes with equivalent containment conditions
Concentration of substance in product Covers percentage substance in the product up to 100 % (unless stated differently)
Vapour pressure @ 25 °C
66 Pa
Conditions and measures related to personal protection, hygiene and health evaluation
Wear a respirator which reduces the air impurities by at least a factor of 10 (APF >= 10)
3.2.4. Control of worker exposure: Contributing scenario controlling worker exposure (PROC3)
PROC3 Manufacture or formulation in the chemical industry in closed batch processes with
occasional controlled exposure or processes with equivalent containment condition
Vapour pressure @ 25 °C
66 Pa
Conditions and measures related to personal protection, hygiene and health evaluation
Wear a respirator which reduces the air impurities by at least a factor of 10 (APF >= 10)
Man via environment - Inhalation (systemic effects) 0.0000783 mg/m³ < 0.01 EUSES 2.1.2
Man via environment - Inhalation (local effects) 0.0000783 mg/m³ < 0.01 EUSES 2.1.2
Man via environment - Oral 0.00793 mg/kg bw/day < 0.01 EUSES 2.1.2
Long term - Local - 4.13 mg/m³ < 0.01 ECETOC TRA v3.0,Worker
Inhalation
3.4. Guidance to Downstream User to evaluate whether he works inside the boundaries set by the ES
3.4.1. Environment
3.4.2. Health